Clinical Trials Browser

Phase 2 × Gastrointestinal Stromal Tumors × Temozolomide × Clear all

NCT03556384 2024-11-04

Temozolomide (TMZ) in Advanced Succinate Dehydrogenase (SDH)-Mutant/Deficient Gastrointestinal Stromal Tumor (GIST)

Phase 2 Active not recruiting

GastrointestinalSarcoma

Hematoma, Subdural, Neoplasms, Gastrointestinal Stromal Tumors

NCT05661643 2024-03-15

GIST

Phase 2 Recruiting

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT00005597 2013-01-03

S9926 Temozolomide in Patients With Unresectable/Metastatic Gastrointestinal Stromal Tumors

Phase 2 Completed

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors